Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ANIK — Anika Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$141,266
+$71,985 QoQ
Shares Held
9,656
+102.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. ANIK ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $141,266 9,656
2026-03-31 $69,281 4,778
2025-12-31 $141,026 14,675
2025-09-30 $95,973 10,210
2025-06-30 $96,817 9,151
2025-03-31 $122,238 8,133
2024-12-31 $122,148 7,421
2024-09-30 $139,851 5,662
2024-06-30 $154,689 6,107
2024-03-31 $131,469 5,176
2023-12-31 $102,264 4,513
2023-09-30 $76,792 4,122
2023-06-30 $293,260 11,288
2023-03-31 $239,926 8,354
2022-12-31 $19,772 668
2022-09-30 $33,295 1,399
2022-06-30 $39,662 1,777
2022-03-31 $401,733 15,999
2021-12-31 $723,800 20,201
2021-09-30 $1,479,725 34,768
2021-06-30 $1,370,561 31,660
2021-03-31 $399,944 9,805
2020-12-31 $8,865,074 195,870
2020-09-30 $6,833,064 193,079
2020-06-30 $7,504,081 198,889
2020-03-31 $6,882,486 238,066